Global Markets Direct’s, ‘GNI Group Ltd. Product Pipeline Review 2014′, provides an overview of the GNI Group Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of GNI Group Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides brief overview of GNI Group Ltd. including business description, key information and facts, and its locations and subsidiaries
• The report reviews current pipeline of GNI Group Ltd.’s human therapeutic division and enlists all their major and minor projects
• The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
• Special feature on out-licensed and partnered product portfolio
• The report summarizes all the dormant and discontinued pipeline projects
• Latest company statement
• Latest news and deals relating to the GNI Group Ltd.’s pipeline products

Reasons to buy

• Evaluate GNI Group Ltd.’s strategic position with total access to detailed information on its product pipeline
• Assess the growth potential of GNI Group Ltd. in its therapy areas of focus
• Identify new drug targets and therapeutic classes in the GNI Group Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
• Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
• Develop strategic initiatives by understanding the focus areas of GNI Group Ltd. and exploit collaboration and partnership opportunities
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by identifying the most promising pipeline of GNI Group Ltd.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Explore the dormant and discontinued projects of GNI Group Ltd. and identify potential opportunities in those areas
• Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
GNI Group Ltd. Snapshot 4
GNI Group Ltd. Overview 4
Key Information 4
Key Facts 4
GNI Group Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
GNI Group Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
GNI Group Ltd. - Pipeline Products Glance 11
GNI Group Ltd. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
GNI Group Ltd. - Early Stage Pipeline Products 13
IND/CTA Filed Products/Combination Treatment Modalities 13
GNI Group Ltd. - Drug Profiles 14
pirfenidone 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
F-351 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
EP-1013 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
GNI Group Ltd. - Pipeline Analysis 18
GNI Group Ltd. - Pipeline Products by Target 18
GNI Group Ltd. - Pipeline Products by Route of Administration 19
GNI Group Ltd. - Pipeline Products by Molecule Type 20
GNI Group Ltd. - Pipeline Products by Mechanism of Action 21
GNI Group Ltd. - Recent Pipeline Updates 22
GNI Group Ltd. - Dormant Projects 23
GNI Group Ltd. - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26

List of Tables

GNI Group Ltd., Key Information 4
GNI Group Ltd., Key Facts 4
GNI Group Ltd. - Pipeline by Indication, 2014 6
GNI Group Ltd. - Pipeline by Stage of Development, 2014 7
GNI Group Ltd. - Monotherapy Products in Pipeline, 2014 8
GNI Group Ltd. - Partnered Products in Pipeline, 2014 9
GNI Group Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 10
GNI Group Ltd. - Phase II, 2014 11
GNI Group Ltd. - Phase I, 2014 12
GNI Group Ltd. - IND/CTA Filed, 2014 13
GNI Group Ltd. - Pipeline by Target, 2014 18
GNI Group Ltd. - Pipeline by Route of Administration, 2014 19
GNI Group Ltd. - Pipeline by Molecule Type, 2014 20
GNI Group Ltd. - Pipeline Products by Mechanism of Action, 2014 21
GNI Group Ltd. - Recent Pipeline Updates, 2014 22
GNI Group Ltd. - Dormant Developmental Projects,2014 23
GNI Group Ltd., Subsidiaries 24

List of Figures

GNI Group Ltd. - Pipeline by Top 10 Indication, 2014 6
GNI Group Ltd. - Pipeline by Stage of Development, 2014 7
GNI Group Ltd. - Monotherapy Products in Pipeline, 2014 8
GNI Group Ltd. - Partnered Products in Pipeline, 2014 9
GNI Group Ltd. - Pipeline by Top 10 Target, 2014 18
GNI Group Ltd. - Pipeline by Top 10 Route of Administration, 2014 19
GNI Group Ltd. - Pipeline by Top 10 Molecule Type, 2014 20
GNI Group Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014 21